ClinicalTrials.Veeva

Menu

Active Surveillance for Low-risk Papillary Thyroid Carcinoma (MAeSTro-EXP)

N

National Cancer Center (NCC)

Status

Invitation-only

Conditions

Papillary Thyroid Carcinoma
Thyroid Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT06261190
H-2308-182-1463

Details and patient eligibility

About

This is a multi-center, non-randomized, prospective observational cohort study aimed at establishing a cohort of low-risk papillary thyroid cancer patients with a maximum tumor diameter of 1.5 cm or less, consisting of an active surveillance group and an immediate surgery group.

Full description

The primary objective of this study is to evaluate the natural course of low-risk papillary thyroid cancer, specifically the progression rates of tumor size increase and the occurrence of local or distant metastasis. Ultimately, it is expected that establishing new criteria for active surveillance of low-risk papillary thyroid cancer in Korean patients will lead to a reduction in unnecessary surgical treatments, improving quality of life and decreasing national healthcare costs.

Enrollment

499 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • subjects over 18 years old with a thyroid nodule of ≤ 1.5 cm in maximum diameter and a Bethesda category V or VI diagnosis on cytopathology
  • subjects without high-risk features, including lymph node (LN) metastasis, distant metastasis, signs or symptoms of invasion to the recurrent laryngeal nerve or trachea, Poorly differentiated cancer or variant with a poor prognosis, such as the tall cell, diffuse sclerosing, columnar cell, or solid variants.

Exclusion criteria

  • subjects who are unable or unwilling to attend regular follow-ups..
  • subjects with a diagnosis of benign, atypia of undetermined significance, suspicious for follicular neoplasm, or follicular neoplasm (Bethesda category II, III, or IV) based on Fine needle aspiration or, or benign, indeterminate by core needle biopsy.

Trial design

499 participants in 2 patient groups

Active surveillance
Description:
Group with active surveillance of their Papillary Thyroid Cancer
Immediate surgery
Description:
Group who underwent surgery after diagnosis Papillary Thyroid Cancer

Trial contacts and locations

4

Loading...

Central trial contact

Eun Kyung Lee

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems